The Cure(ious)TM
February 19, 2025
Munjal Shah, Co-Founder and CEO of Hippocratic AI, was recently featured in “The Cure(ious)” series by the New York Stock Exchange (NYSE). This series invites
A generative artificial intelligence startup focused on building foundation models for health care and using it to improve patient outcomes, lower health care costs, and address the growing shortage of health care workers worldwide.
Founded by generative AI researchers, hospital administrators, physicians, and Medicare experts, Hippocratic AI has developed a safety-focused large language model to provide nondiagnostic health care services. Its large language model outperformed Open AI’s GPT-4 on 105 of 114 health care exams and certifications. Hippocratic AI has received a total of $120M in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, and SV Angel.
Munjal Shah, Co-Founder and CEO of Hippocratic AI, was recently featured in “The Cure(ious)” series by the New York Stock Exchange (NYSE). This series invites
I was recently a guest speaker at CES, where we delved into a range of compelling topics. The discussion highlighted the critical role of empathy
Hippocratic AI is expanding its presence in life sciences by acquiring Grove AI, a startup focused on agentic AI for pharma R&D and clinical trial
Hippocratic AI has entered a collaboration with Huron Consulting Group to integrate generative AI healthcare agents into Huron-led healthcare transformation programs. The initiative is designed
Hippocratic AI has formed a partnership with Boston Consulting Group to support the biopharma and medtech industries in implementing generative AI healthcare agents at scale.